Economic Burden of High-Responding Inhibitors in Patients with Hemophilia A in Taiwan

PURPOSE: Hemophilia A (HA) is the most common X-linked inherited bleeding disorder. In some patients with HA, particularly those with severe HA, replacement therapy results in the production of high-responding clotting factor VIII inhibitors. The economic burden of this complication is the highest r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Tsu-Chiang, Cheng, Shin-Nan, Chen, Jye-Daa, Cham, Thau-Ming, Chung, Mei-Ing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575981/
https://www.ncbi.nlm.nih.gov/pubmed/23364968
http://dx.doi.org/10.3349/ymj.2013.54.2.358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575981/
https://www.ncbi.nlm.nih.gov/pubmed/23364968
http://dx.doi.org/10.3349/ymj.2013.54.2.358

Ejemplares similares